Sarcopenia is the loss of muscle strength, mass, and function, which is often exacerbated by
chronic comorbidities including cardiovascular diseases, chronic kidney disease, and …

With the advent of population aging, aging-related diseases have become a challenge for
governments worldwide. Sarcopenia has defined as a clinical syndrome associated with …

Sarcopenia is an age‐related disease and is often accompanied by other diseases. Now,
many studies have shown that cardiovascular diseases (CVDs) may raise the incidence rate …

Sarcopenia is a prevalent problem in the older population that is commonly considered for
its well-known adverse functional associations. Cardiovascular diseases and metabolic …

Sarcopenia has been established as a predictor of poor outcomes in various clinical
settings. It is particularly prevalent in heart failure, a clinical syndrome that poses significant …

Sarcopenia is defined as an age associated decline in skeletal muscle mass. The
pathophysiology of sarcopenia is multifactorial, with decreased caloric intake, muscle fiber …

Sarcopenia, the lowered skeletal muscle mass, weakened skeletal muscle strength, and
reduced physical performance with aging, is a component of frailty and high-risk factor for …

Sarcopenia is an age-related geriatric syndrome that is characterized by a progressive loss
of muscle mass, strength and function. Chronic heart failure (CHF), the final stage of various …

Chronic heart failure (CHF) is a highly prevalent condition among the elderly and is
associated with considerable morbidity, institutionalization and mortality. In its advanced …

Sarcopenia is an age-associated loss of muscle mass and decline in muscle strength; it is
common in older adults and is associated with significant morbidity and mortality. Despite its …